tizanidine
- Product NDC
- 68071-3288
- 11-digit product format
- 680713288
- Labeler code
- 68071
- Product ID
- 68071-3288_bb1723c5-7164-d227-e053-2995a90a35e4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals, Inc.
- Application
- ANDA076533
- Marketing category
- ANDA
- Marketing start
- 2004-01-16
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68071-3288-3 | 68071328803 | 30 TABLET in 1 BOTTLE (68071-3288-3) | 30 tablet | 2017-06-07 | 0000-00-00 | No | No | Current |
| 68071-3288-6 | 68071328806 | 60 TABLET in 1 BOTTLE (68071-3288-6) | 60 tablet | 2017-06-07 | 0000-00-00 | No | No | Current |
| 68071-3288-9 | 68071328809 | 90 TABLET in 1 BOTTLE (68071-3288-9) | 90 tablet | 2017-06-07 | 0000-00-00 | No | No | Current |